Irving-based McKesson adds to D-FW sublease office glut dallasnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dallasnews.com Daily Mail and Mail on Sunday newspapers.
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS® , the first and only FDA approved treatment for Friedreich’s ataxia in the U.S. CAMBRIDGE, Mass., Sept..
Reata Pharmaceuticals (NASDAQ:RETA) Receives Neutral Rating from Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Reata Pharmaceuticals (NASDAQ:RETA) Earns "Neutral" Rating from Cantor Fitzgerald theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.